Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
What Is Semaglutide?
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that mimics a naturally occurring hormone involved in appetite regulation, blood sugar control, and digestion.
Semaglutide is available in FDA-approved formulations, including once-weekly injections and oral tablets, depending on the prescribed product and treatment indication.
Potential Benefits
Effective Weight Management: Clinical studies demonstrate significant weight reduction when semaglutide is combined with healthy nutrition, physical activity, and lifestyle modifications.
Appetite Suppression: Helps reduce hunger, food cravings, and overall calorie intake.
Increased Satiety: Slows gastric emptying, helping patients feel fuller for longer periods.
Improved Blood Sugar Control: Supports glucose regulation and insulin secretion in a glucose-dependent manner, particularly in patients with type 2 diabetes.
Improved Metabolic Health: Weight reduction may improve blood pressure, cholesterol levels, and other cardiometabolic risk factors.
Additional Health Benefits: Certain FDA-approved semaglutide products have demonstrated cardiovascular and other health benefits in specific patient populations.
Common Side Effects
Most side effects involve the gastrointestinal system and are more common when beginning treatment or increasing the dosage.
Nausea or vomiting
Diarrhea or constipation
Abdominal discomfort or bloating
Indigestion, acid reflux, or burping
Decreased appetite
Fatigue
Headache
Injection-site reactions with injectable formulations
Many gastrointestinal side effects decrease as the body adjusts to treatment.
Important Safety Information
Semaglutide may cause serious adverse effects, including pancreatitis, gallbladder disease, dehydration-related kidney injury, severe gastrointestinal reactions, and serious allergic reactions.
Low blood sugar may occur, particularly when semaglutide is combined with insulin or certain diabetes medications.
Semaglutide carries a boxed warning regarding thyroid C-cell tumors observed in animal studies. It should not be used in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2).
Semaglutide is not recommended for patients with severe gastroparesis. Patients should inform their provider about any history of diabetic retinopathy, pregnancy plans, breastfeeding, or upcoming procedures requiring anesthesia or deep sedation.
Patients planning pregnancy should discontinue semaglutide at least two months before attempting conception, under the guidance of their healthcare provider.
Our Approach at Scottsboro Weight Loss
At Scottsboro Weight Loss, we understand that successful weight management requires an individualized approach.
Our licensed medical providers evaluate each patient's medical history, health conditions, and personal goals to determine whether semaglutide is an appropriate treatment option.
Through personalized nutrition plans, InBody 580 body composition monitoring, lifestyle guidance, and ongoing medical supervision, we help patients work toward sustainable weight management while prioritizing safety and long-term wellness.
Compounded semaglutide is not FDA-approved and has not undergone FDA review for safety, effectiveness, or quality. Compounded medications may be prescribed only when legally permitted and clinically appropriate for an individual patient's medical needs. Results vary, and treatment requires evaluation by a licensed healthcare provider.
What Is Semaglutide?
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that mimics a naturally occurring hormone involved in appetite regulation, blood sugar control, and digestion.
Semaglutide is available in FDA-approved formulations, including once-weekly injections and oral tablets, depending on the prescribed product and treatment indication.
Potential Benefits
Effective Weight Management: Clinical studies demonstrate significant weight reduction when semaglutide is combined with healthy nutrition, physical activity, and lifestyle modifications.
Appetite Suppression: Helps reduce hunger, food cravings, and overall calorie intake.
Increased Satiety: Slows gastric emptying, helping patients feel fuller for longer periods.
Improved Blood Sugar Control: Supports glucose regulation and insulin secretion in a glucose-dependent manner, particularly in patients with type 2 diabetes.
Improved Metabolic Health: Weight reduction may improve blood pressure, cholesterol levels, and other cardiometabolic risk factors.
Additional Health Benefits: Certain FDA-approved semaglutide products have demonstrated cardiovascular and other health benefits in specific patient populations.
Common Side Effects
Most side effects involve the gastrointestinal system and are more common when beginning treatment or increasing the dosage.
Nausea or vomiting
Diarrhea or constipation
Abdominal discomfort or bloating
Indigestion, acid reflux, or burping
Decreased appetite
Fatigue
Headache
Injection-site reactions with injectable formulations
Many gastrointestinal side effects decrease as the body adjusts to treatment.
Important Safety Information
Semaglutide may cause serious adverse effects, including pancreatitis, gallbladder disease, dehydration-related kidney injury, severe gastrointestinal reactions, and serious allergic reactions.
Low blood sugar may occur, particularly when semaglutide is combined with insulin or certain diabetes medications.
Semaglutide carries a boxed warning regarding thyroid C-cell tumors observed in animal studies. It should not be used in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2).
Semaglutide is not recommended for patients with severe gastroparesis. Patients should inform their provider about any history of diabetic retinopathy, pregnancy plans, breastfeeding, or upcoming procedures requiring anesthesia or deep sedation.
Patients planning pregnancy should discontinue semaglutide at least two months before attempting conception, under the guidance of their healthcare provider.
Our Approach at Scottsboro Weight Loss
At Scottsboro Weight Loss, we understand that successful weight management requires an individualized approach.
Our licensed medical providers evaluate each patient's medical history, health conditions, and personal goals to determine whether semaglutide is an appropriate treatment option.
Through personalized nutrition plans, InBody 580 body composition monitoring, lifestyle guidance, and ongoing medical supervision, we help patients work toward sustainable weight management while prioritizing safety and long-term wellness.
Compounded semaglutide is not FDA-approved and has not undergone FDA review for safety, effectiveness, or quality. Compounded medications may be prescribed only when legally permitted and clinically appropriate for an individual patient's medical needs. Results vary, and treatment requires evaluation by a licensed healthcare provider.
